Literature DB >> 8292028

Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes.

N Ito1, S Kawata, S Tamura, S Kiso, H Tsushima, D Damm, J A Abraham, S Higashiyama, N Taniguchi, Y Matsuzawa.   

Abstract

We examined the hepatotrophic activity of heparin-binding EGF-like growth factor (HB-EGF), a recently identified potent mitogen for vascular smooth muscle cells and fibroblasts. HB-EGF stimulated DNA synthesis of rat hepatocytes in primary culture in a dose-dependent manner up to 30 ng/ml. The maximal stimulation by HB-EGF represented more than 80% of that induced by HGF. In normal rat liver, the transcript of HB-EGF gene was detected in the non-parenchymal cells and very low level in the hepatocytes. In the regenerating liver on the 3rd day after 70% hepatectomy, the HB-EGF mRNA increased in the non-parenchymal cells, suggesting that HB-EGF may contribute to liver regeneration through a paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8292028     DOI: 10.1006/bbrc.1994.1004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma.

Authors:  Y Ito; S Higashiyama; T Takeda; Y Yamamoto; K I Wakasa; N Matsuura
Journal:  Int J Pancreatol       Date:  2001

Review 2.  Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration.

Authors:  Duy T Dao; Lorenzo Anez-Bustillos; Rosalyn M Adam; Mark Puder; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2018-08-22       Impact factor: 4.307

3.  Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.

Authors:  Hye Won Chung; Hoon Young Kong; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

4.  Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.

Authors:  K Goishi; S Higashiyama; M Klagsbrun; N Nakano; T Umata; M Ishikawa; E Mekada; N Taniguchi
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

5.  Toxicokinetic study of recombinant human heparin-binding epidermal growth factor-like growth factor (rhHB-EGF) in female Sprague Dawley rats.

Authors:  Intira Coowanitwong; Susan K Keay; Karthika Natarajan; Tushar S Garimella; Clifford W Mason; David Grkovic; Kenneth S Bauer
Journal:  Pharm Res       Date:  2007-08-01       Impact factor: 4.200

6.  EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration.

Authors:  Alexandra Collin de L'hortet; Hélène Gilgenkrantz; Jacques-Emmanuel Guidotti
Journal:  Int J Hepatol       Date:  2012-09-23

7.  Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis.

Authors:  Tong Zhou; Wei Zhang; Nadera J Sweiss; Edward S Chen; David R Moller; Kenneth S Knox; Shwu-Fan Ma; Michael S Wade; Imre Noth; Roberto F Machado; Joe G N Garcia
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

8.  Signals and cells involved in regulating liver regeneration.

Authors:  Liang-I Kang; Wendy M Mars; George K Michalopoulos
Journal:  Cells       Date:  2012-12-13       Impact factor: 6.600

Review 9.  EGFR Signaling in Liver Diseases.

Authors:  Karin Komposch; Maria Sibilia
Journal:  Int J Mol Sci       Date:  2015-12-29       Impact factor: 5.923

10.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.

Authors:  S Higashiyama; R Iwamoto; K Goishi; G Raab; N Taniguchi; M Klagsbrun; E Mekada
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.